Platform for detecting post-operative complications

GET CONNECTED
fluidai.md

Team

Mohamed Okasha

Lead Scientist

Abdallah El-Falou

CTO

Youssef Helwa

CEO

Amr Abdelgawad

COO

FluidAI

Company details

NERv is creating the first-ever platform to detect post-operative complications in real-time. Their technology utilizes biosensors to monitor natural biomarkers inside the body, detecting abnormal changes and reporting them immediately to the patient and their medical team.

Human HealthCanadaSeries A(+)DiagnosticsHard TechHealthcareHuman HealthRemote CareHAX 2018

Company News

NERv Technology secures US $2.65M seed financing led by SOSV

April 23, 2021
Private Capital Journal

NERV TECHNOLOGY RAISES $3.32 MILLION AS IT PREPARES TO BRING MEDICAL SENSOR TECH TO MARKET

April 23, 2021
BetaKit

NERv Technology Inc. continues building a future of safe surgeries with latest round of funding

October 9, 2019
University of Waterloo

Get In Touch with FluidAI

Please tell us a little bit about yourself and why you'd like to get connected. FluidAI + SOSV will follow up with you via email.

Hidden
Hidden
Hidden
Hidden
Opt-in checkbox


We don’t spam. Our Privacy Policy and Terms of Use apply.
* If you are interested in investing directly into SOSV's portfolio of privately held companies, or into SOSV's funds, you need to meet the SEC’s criteria for accredited investor status. As an individual, you can qualify as an accredited investor by either (a) having more than $200,000 in annual income for each of the past two years (or $300,000 with your spouse) and a reasonable expectation of earning the same this year or (b) having a net worth of at least $1 million (not including your principal residence). Learn More